- Home
- PENN vs ALVO Comparison
PENN vs ALVO Comparison
Compare PENN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENN
- ALVO
- Stock Information
- Founded
- PENN 1972
- ALVO 2013
- Country
- PENN United States
- ALVO Luxembourg
- Employees
- PENN N/A
- ALVO N/A
- Industry
- PENN Hotels/Resorts
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- PENN Consumer Discretionary
- ALVO Health Care
- Exchange
- PENN Nasdaq
- ALVO Nasdaq
- Market Cap
- PENN 3.1B
- ALVO 3.5B
- IPO Year
- PENN 1994
- ALVO N/A
- Fundamental
- Price
- PENN $20.22
- ALVO $12.39
- Analyst Decision
- PENN Buy
- ALVO Buy
- Analyst Count
- PENN 18
- ALVO 1
- Target Price
- PENN $23.23
- ALVO $18.00
- AVG Volume (30 Days)
- PENN 2.7M
- ALVO 89.9K
- Earning Date
- PENN 11-07-2024
- ALVO 11-13-2024
- Dividend Yield
- PENN N/A
- ALVO N/A
- EPS Growth
- PENN N/A
- ALVO N/A
- EPS
- PENN N/A
- ALVO N/A
- Revenue
- PENN $6,304,500,000.00
- ALVO $393,919,000.00
- Revenue This Year
- PENN $6.63
- ALVO $382.28
- Revenue Next Year
- PENN $5.63
- ALVO $50.44
- P/E Ratio
- PENN N/A
- ALVO N/A
- Revenue Growth
- PENN N/A
- ALVO 517.92
- 52 Week Low
- PENN $13.50
- ALVO $9.00
- 52 Week High
- PENN $27.21
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- PENN 52.74
- ALVO 33.54
- Support Level
- PENN $19.63
- ALVO $12.58
- Resistance Level
- PENN $21.75
- ALVO $13.14
- Average True Range (ATR)
- PENN 0.82
- ALVO 0.46
- MACD
- PENN -0.05
- ALVO -0.16
- Stochastic Oscillator
- PENN 55.78
- ALVO 2.48
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 89% of total sales in 2023; 11% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.